Inhaled Corticosteroid/Long-Acting β₂-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe

By  

International Archives of Allergy and Immunology, Vol. 157, Iss. 3, 2011-11 ,pp. : 303-310

Karger

Access to resources Recommend Favorite

Appropriate use of inhaled corticosteroid and long-acting ßß₂-adrenergic agonist combination therapy among asthma patients in a US commercially insured population

By Ye Xin   Gutierrez Benjamin   Zarotsky Victoria   Nelson Michael   Blanchette Christopher M.  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2251-2258

Informa Healthcare

Access to resources Recommend Favorite

Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1153-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Indacaterol, a novel inhaled, once-daily, long-acting beta 2 -agonist for the treatment of obstructive airways diseases

By Beeh Kai  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite

Plasma C-Reactive Protein and 5-Lipoxygenase-Activating Protein Gene Promoter Poly-A Polymorphism in Patients with Coronary Artery Disease

By  

Cardiology, Vol. 109, Iss. 1, 2007-07 ,pp. : 25-32

Karger

Access to resources Recommend Favorite